APO Research
Talk to an analyst

APO RESEARCH · REPORT

Multi-target MET TKIs

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Multi-target MET TKIs Industry Growth and Trends Forecast to 2032

27 December 2025105 pages

Choose your research edition.

Industry ResearchMulti-target MET TKIs Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Multi-target MET TKIs Industry Growth and Trends Forecast to 2032105 pages · $3,450 USDMarket StructureGlobal Multi-target MET TKIs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Multi-target MET TKIs Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Multi-target MET TKIs Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Multi-target MET TKIs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Multi-target MET TKIs is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Multi-target MET TKIs is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Multi-target MET TKIs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Multi-target MET TKIs include BDR Pharma, Beacon Pharmaceuticals, Drug International, Elemento Pharma, Everest Pharmaceuticals, Exelixis, Genvio Pharma, MSN Labs and Zydus, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Multi-target MET TKIs market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Multi-target MET TKIs market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Multi-target MET TKIs market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Multi-target MET TKIs.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Multi-target MET TKIs market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Multi-target MET TKIs Market by Company

BDR Pharma

Beacon Pharmaceuticals

Drug International

Elemento Pharma

Everest Pharmaceuticals

Exelixis

Genvio Pharma

MSN Labs

Zydus

Pfizer

Stada Arzneimittel

Teva

万邦医药

Cipla

Multi-target MET TKIs Segment by Type

Crizotinib

cabozantinib

Other

Multi-target MET TKIs Segment by Application

Medullary Thyroid Cancer

Non-small Cell Lung Cancer

Other

Multi-target MET TKIs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Multi-target MET TKIs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Multi-target MET TKIs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Multi-target MET TKIs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Multi-target MET TKIs manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Multi-target MET TKIs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Crizotinib Table 2. Major Company of cabozantinib Table 3. Major Company of Other Table 4. Global Multi-target MET TKIs Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Multi-target MET TKIs Sales by Type (2021-2026) & (K Units) Table 6. Global Multi-target MET TKIs Sales Market Share in Volume by Type (2021-2026) Table 7. Global Multi-target MET TKIs Sales by Type (2021-2026) & (US$ Million) Table 8. Global Multi-target MET TKIs Sales Market Share in Value by Type (2021-2026) Table 9. Global Multi-target MET TKIs Price by Type (2021-2026) & (US$/Unit) Table 10. Global Multi-target MET TKIs Sales by Type (2027-2032) & (K Units) Table 11. Global Multi-target MET TKIs Sales Market Share in Volume by Type (2027-2032) Table 12. Global Multi-target MET TKIs Sales by Type (2027-2032) & (US$ Million) Table 13. Global Multi-target MET TKIs Sales Market Share in Value by Type (2027-2032) Table 14. Global Multi-target MET TKIs Price by Type (2027-2032) & (US$/Unit) Table 15. North America Multi-target MET TKIs Sales by Type (2021-2026) & (K Units) Table 16. North America Multi-target MET TKIs Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Multi-target MET TKIs Sales by Type (2021-2026) & (K Units) Table 18. Europe Multi-target MET TKIs Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Multi-target MET TKIs Sales by Type (2021-2026) & (K Units) Table 20. Asia-Pacific Multi-target MET TKIs Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Multi-target MET TKIs Sales by Type (2021-2026) & (K Units) Table 22. Latin America Multi-target MET TKIs Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Multi-target MET TKIs Sales by Type (2021-2026) & (K Units) Table 24. Middle East and Africa Multi-target MET TKIs Sales by Type (2021-2026) & (US$ Million) Table 25. Multi-target MET TKIs Industry Trends Table 26. Multi-target MET TKIs Industry Drivers Table 27. Multi-target MET TKIs Industry Opportunities and Challenges Table 28. Multi-target MET TKIs Industry Restraints Table 29. Global Multi-target MET TKIs Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Multi-target MET TKIs Revenue Market Share by Company (2021-2026) Table 31. Global Multi-target MET TKIs Sales by Company (2021-2026) & (K Units) Table 32. Global Multi-target MET TKIs Sales Share by Company (2021-2026) Table 33. Global Multi-target MET TKIs Market Price by Company (2021-2026) & (US$/Unit) Table 34. Global Multi-target MET TKIs Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Multi-target MET TKIs Major Company Production Sites and Headquarters Table 36. Global Multi-target MET TKIs Company, Product Type & Application Table 37. Global Multi-target MET TKIs Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Multi-target MET TKIs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Multi-target MET TKIs Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Multi-target MET TKIs Sales by Region (2021-2026) & (K Units) Table 42. Global Multi-target MET TKIs Sales Market Share in Volume by Region (2021-2026) Table 43. Global Multi-target MET TKIs Sales by Region (2021-2026) & (US$ Million) Table 44. Global Multi-target MET TKIs Sales Market Share in Value by Region (2021-2026) Table 45. Global Multi-target MET TKIs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Global Multi-target MET TKIs Sales by Region (2027-2032) & (K Units) Table 47. Global Multi-target MET TKIs Sales Market Share in Volume by Region (2027-2032) Table 48. Global Multi-target MET TKIs Sales by Region (2027-2032) & (US$ Million) Table 49. Global Multi-target MET TKIs Sales Market Share in Value by Region (2027-2032) Table 50. Global Multi-target MET TKIs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 51. Global Multi-target MET TKIs Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Multi-target MET TKIs Sales by Application (2021-2026) & (K Units) Table 53. Global Multi-target MET TKIs Sales Market Share in Volume by Application (2021-2026) Table 54. Global Multi-target MET TKIs Sales by Application (2021-2026) & (US$ Million) Table 55. Global Multi-target MET TKIs Sales Market Share in Value by Application (2021-2026) Table 56. Global Multi-target MET TKIs Price by Application (2021-2026) & (US$/Unit) Table 57. Global Multi-target MET TKIs Sales by Application (2027-2032) & (K Units) Table 58. Global Multi-target MET TKIs Sales Market Share in Volume by Application (2027-2032) Table 59. Global Multi-target MET TKIs Sales by Application (2027-2032) & (US$ Million) Table 60. Global Multi-target MET TKIs Sales Market Share in Value by Application (2027-2032) Table 61. Global Multi-target MET TKIs Price by Application (2027-2032) & (US$/Unit) Table 62. North America Multi-target MET TKIs Sales by Application (2021-2026) & (K Units) Table 63. North America Multi-target MET TKIs Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Multi-target MET TKIs Sales by Application (2021-2026) & (K Units) Table 65. Europe Multi-target MET TKIs Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Multi-target MET TKIs Sales by Application (2021-2026) & (K Units) Table 67. Asia-Pacific Multi-target MET TKIs Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Multi-target MET TKIs Sales by Application (2021-2026) & (K Units) Table 69. Latin America Multi-target MET TKIs Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Multi-target MET TKIs Sales by Application (2021-2026) & (K Units) Table 71. Middle East and Africa Multi-target MET TKIs Sales by Application (2021-2026) & (US$ Million) Table 72. BDR Pharma Company Information Table 73. BDR Pharma Business Overview Table 74. BDR Pharma Multi-target MET TKIs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. BDR Pharma Multi-target MET TKIs Product Portfolio Table 76. BDR Pharma Recent Development Table 77. Beacon Pharmaceuticals Company Information Table 78. Beacon Pharmaceuticals Business Overview Table 79. Beacon Pharmaceuticals Multi-target MET TKIs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Beacon Pharmaceuticals Multi-target MET TKIs Product Portfolio Table 81. Beacon Pharmaceuticals Recent Development Table 82. Drug International Company Information Table 83. Drug International Business Overview Table 84. Drug International Multi-target MET TKIs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Drug International Multi-target MET TKIs Product Portfolio Table 86. Drug International Recent Development Table 87. Elemento Pharma Company Information Table 88. Elemento Pharma Business Overview Table 89. Elemento Pharma Multi-target MET TKIs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Elemento Pharma Multi-target MET TKIs Product Portfolio Table 91. Elemento Pharma Recent Development Table 92. Everest Pharmaceuticals Company Information Table 93. Everest Pharmaceuticals Business Overview Table 94. Everest Pharmaceuticals Multi-target MET TKIs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Everest Pharmaceuticals Multi-target MET TKIs Product Portfolio Table 96. Everest Pharmaceuticals Recent Development Table 97. Exelixis Company Information Table 98. Exelixis Business Overview Table 99. Exelixis Multi-target MET TKIs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. Exelixis Multi-target MET TKIs Product Portfolio Table 101. Exelixis Recent Development Table 102. Genvio Pharma Company Information Table 103. Genvio Pharma Business Overview Table 104. Genvio Pharma Multi-target MET TKIs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. Genvio Pharma Multi-target MET TKIs Product Portfolio Table 106. Genvio Pharma Recent Development Table 107. MSN Labs Company Information Table 108. MSN Labs Business Overview Table 109. MSN Labs Multi-target MET TKIs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. MSN Labs Multi-target MET TKIs Product Portfolio Table 111. MSN Labs Recent Development Table 112. Zydus Company Information Table 113. Zydus Business Overview Table 114. Zydus Multi-target MET TKIs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 115. Zydus Multi-target MET TKIs Product Portfolio Table 116. Zydus Recent Development Table 117. Pfizer Company Information Table 118. Pfizer Business Overview Table 119. Pfizer Multi-target MET TKIs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 120. Pfizer Multi-target MET TKIs Product Portfolio Table 121. Pfizer Recent Development Table 122. Stada Arzneimittel Company Information Table 123. Stada Arzneimittel Business Overview Table 124. Stada Arzneimittel Multi-target MET TKIs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 125. Stada Arzneimittel Multi-target MET TKIs Product Portfolio Table 126. Stada Arzneimittel Recent Development Table 127. Teva Company Information Table 128. Teva Business Overview Table 129. Teva Multi-target MET TKIs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 130. Teva Multi-target MET TKIs Product Portfolio Table 131. Teva Recent Development Table 132. 万邦医药 Company Information Table 133. 万邦医药 Business Overview Table 134. 万邦医药 Multi-target MET TKIs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 135. 万邦医药 Multi-target MET TKIs Product Portfolio Table 136. 万邦医药 Recent Development Table 137. Cipla Company Information Table 138. Cipla Business Overview Table 139. Cipla Multi-target MET TKIs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 140. Cipla Multi-target MET TKIs Product Portfolio Table 141. Cipla Recent Development Table 142. North America Multi-target MET TKIs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 143. North America Multi-target MET TKIs Sales by Country (2021-2026) & (K Units) Table 144. North America Multi-target MET TKIs Sales Market Share by Country (2021-2026) Table 145. North America Multi-target MET TKIs Sales Forecast by Country (2027-2032) & (K Units) Table 146. North America Multi-target MET TKIs Sales Market Share Forecast by Country (2027-2032) Table 147. North America Multi-target MET TKIs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 148. North America Multi-target MET TKIs Market Size by Country (2021-2026) & (US$ Million) Table 149. North America Multi-target MET TKIs Market Share by Country (2021-2026) Table 150. North America Multi-target MET TKIs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 151. North America Multi-target MET TKIs Market Share Forecast by Country (2027-2032) Table 152. Europe Multi-target MET TKIs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 153. Europe Multi-target MET TKIs Sales by Country (2021-2026) & (K Units) Table 154. Europe Multi-target MET TKIs Sales Market Share by Country (2021-2026) Table 155. Europe Multi-target MET TKIs Sales Forecast by Country (2027-2032) & (K Units) Table 156. Europe Multi-target MET TKIs Sales Market Share Forecast by Country (2027-2032) Table 157. Europe Multi-target MET TKIs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 158. Europe Multi-target MET TKIs Market Size by Country (2021-2026) & (US$ Million) Table 159. Europe Multi-target MET TKIs Market Share by Country (2021-2026) Table 160. Europe Multi-target MET TKIs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 161. Europe Multi-target MET TKIs Market Share Forecast by Country (2027-2032) Table 162. Asia-Pacific Multi-target MET TKIs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 163. Asia-Pacific Multi-target MET TKIs Sales by Country (2021-2026) & (K Units) Table 164. Asia-Pacific Multi-target MET TKIs Sales Market Share by Country (2021-2026) Table 165. Asia-Pacific Multi-target MET TKIs Sales Forecast by Country (2027-2032) & (K Units) Table 166. Asia-Pacific Multi-target MET TKIs Sales Market Share Forecast by Country (2027-2032) Table 167. Asia-Pacific Multi-target MET TKIs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 168. Asia-Pacific Multi-target MET TKIs Market Size by Country (2021-2026) & (US$ Million) Table 169. Asia-Pacific Multi-target MET TKIs Market Share by Country (2021-2026) Table 170. Asia-Pacific Multi-target MET TKIs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 171. Asia-Pacific Multi-target MET TKIs Market Share Forecast by Country (2027-2032) Table 172. Latin America Multi-target MET TKIs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 173. Latin America Multi-target MET TKIs Sales by Country (2021-2026) & (K Units) Table 174. Latin America Multi-target MET TKIs Sales Market Share by Country (2021-2026) Table 175. Latin America Multi-target MET TKIs Sales Forecast by Country (2027-2032) & (K Units) Table 176. Latin America Multi-target MET TKIs Sales Market Share Forecast by Country (2027-2032) Table 177. Latin America Multi-target MET TKIs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 178. Latin America Multi-target MET TKIs Market Size by Country (2021-2026) & (US$ Million) Table 179. Latin America Multi-target MET TKIs Market Share by Country (2021-2026) Table 180. Latin America Multi-target MET TKIs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 181. Latin America Multi-target MET TKIs Market Share Forecast by Country (2027-2032) Table 182. Middle East and Africa Multi-target MET TKIs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 183. Middle East and Africa Multi-target MET TKIs Sales by Country (2021-2026) & (K Units) Table 184. Middle East and Africa Multi-target MET TKIs Sales Market Share by Country (2021-2026) Table 185. Middle East and Africa Multi-target MET TKIs Sales Forecast by Country (2027-2032) & (K Units) Table 186. Middle East and Africa Multi-target MET TKIs Sales Market Share Forecast by Country (2027-2032) Table 187. Middle East and Africa Multi-target MET TKIs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 188. Middle East and Africa Multi-target MET TKIs Market Size by Country (2021-2026) & (US$ Million) Table 189. Middle East and Africa Multi-target MET TKIs Market Share by Country (2021-2026) Table 190. Middle East and Africa Multi-target MET TKIs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 191. Middle East and Africa Multi-target MET TKIs Market Share Forecast by Country (2027-2032) Table 192. Key Raw Materials Table 193. Raw Materials Key Suppliers Table 194. Multi-target MET TKIs Distributors List Table 195. Multi-target MET TKIs Customers List Table 196. Research Programs/Design for This Report Table 197. Authors List of This Report Table 198. Secondary Sources Table 199. Primary Sources List of Figures Figure 1. Multi-target MET TKIs Image Figure 2. Global Multi-target MET TKIs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Multi-target MET TKIs Market Size (2021-2032) & (US$ Million) Figure 4. Global Multi-target MET TKIs Sales (2021-2032) & (K Units) Figure 5. Crizotinib Image Figure 6. Global Crizotinib Sales YoY Growth (2021-2032) & (K Units) Figure 7. cabozantinib Image Figure 8. Global cabozantinib Sales YoY Growth (2021-2032) & (K Units) Figure 9. Other Image Figure 10. Global Other Sales YoY Growth (2021-2032) & (K Units) Figure 11. Global Multi-target MET TKIs Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Multi-target MET TKIs Market Share by Type 2025 VS 2032 Figure 13. North America Multi-target MET TKIs Sales Market Share in Volume by Type in 2025 Figure 14. North America Multi-target MET TKIs Sales Market Share in Value by Type in 2025 Figure 15. Europe Multi-target MET TKIs Sales Market Share in Volume by Type in 2025 Figure 16. Europe Multi-target MET TKIs Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Multi-target MET TKIs Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Multi-target MET TKIs Sales Market Share in Value by Type in 2025 Figure 19. Latin America Multi-target MET TKIs Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Multi-target MET TKIs Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Multi-target MET TKIs Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Multi-target MET TKIs Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Multi-target MET TKIs Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Medullary Thyroid Cancer Image Figure 26. Global Medullary Thyroid Cancer Sales YoY Growth (2021-2032) & (K Units) Figure 27. Non-small Cell Lung Cancer Image Figure 28. Global Non-small Cell Lung Cancer Sales YoY Growth (2021-2032) & (K Units) Figure 29. Other Image Figure 30. Global Other Sales YoY Growth (2021-2032) & (K Units) Figure 31. Global Multi-target MET TKIs Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Multi-target MET TKIs Market Share by Application 2025 VS 2032 Figure 33. North America Multi-target MET TKIs Sales Market Share in Volume by Application in 2025 Figure 34. North America Multi-target MET TKIs Sales Market Share in Value by Application in 2025 Figure 35. Europe Multi-target MET TKIs Sales Market Share in Volume by Application in 2025 Figure 36. Europe Multi-target MET TKIs Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Multi-target MET TKIs Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Multi-target MET TKIs Sales Market Share in Value by Application in 2025 Figure 39. Latin America Multi-target MET TKIs Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Multi-target MET TKIs Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Multi-target MET TKIs Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Multi-target MET TKIs Sales Market Share in Value by Application in 2025 Figure 43. North America Multi-target MET TKIs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 44. North America Multi-target MET TKIs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Multi-target MET TKIs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Multi-target MET TKIs Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Multi-target MET TKIs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. Europe Multi-target MET TKIs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Multi-target MET TKIs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Multi-target MET TKIs Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Multi-target MET TKIs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Asia-Pacific Multi-target MET TKIs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Multi-target MET TKIs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Multi-target MET TKIs Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Multi-target MET TKIs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Latin America Multi-target MET TKIs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Multi-target MET TKIs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Multi-target MET TKIs Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Multi-target MET TKIs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 60. Middle East and Africa Multi-target MET TKIs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Multi-target MET TKIs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Multi-target MET TKIs Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Multi-target MET TKIs Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Multi-target MET TKIs Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Crizotinib
  • cabozantinib
  • Other
Applications
  • Medullary Thyroid Cancer
  • Non-small Cell Lung Cancer
  • Other
Companies covered
  • BDR Pharma
  • Beacon Pharmaceuticals
  • Drug International
  • Elemento Pharma
  • Everest Pharmaceuticals
  • Exelixis
  • Genvio Pharma
  • MSN Labs
  • Zydus
  • Pfizer
  • Stada Arzneimittel
  • Teva
  • 万邦医药
  • Cipla

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Multi-target MET TKIs Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Multi-target MET TKIs Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Multi-target MET TKIs Market by Type
  6. 1.3.1 Crizotinib
  7. 1.3.2 cabozantinib
  8. 1.3.3 Other
  9. 1.4 Global Multi-target MET TKIs Market Size by Type
  10. 1.4.1 Global Multi-target MET TKIs Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Multi-target MET TKIs Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Multi-target MET TKIs Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Multi-target MET TKIs Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Multi-target MET TKIs Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Multi-target MET TKIs Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Multi-target MET TKIs Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Multi-target MET TKIs Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Multi-target MET TKIs Industry Trends
  2. 2.2 Multi-target MET TKIs Industry Drivers
  3. 2.3 Multi-target MET TKIs Industry Opportunities and Challenges
  4. 2.4 Multi-target MET TKIs Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Multi-target MET TKIs Revenue (2021-2026)
  2. 3.2 Global Top Players by Multi-target MET TKIs Sales (2021-2026)
  3. 3.3 Global Top Players by Multi-target MET TKIs Price (2021-2026)
  4. 3.4 Global Multi-target MET TKIs Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Multi-target MET TKIs Major Company Production Sites & Headquarters
  6. 3.6 Global Multi-target MET TKIs Company, Product Type & Application
  7. 3.7 Global Multi-target MET TKIs Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Multi-target MET TKIs Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Multi-target MET TKIs Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Multi-target MET TKIs Tier 1, Tier 2, and Tier 3
4 Multi-target MET TKIs Regional Status and Outlook
  1. 4.1 Global Multi-target MET TKIs Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Multi-target MET TKIs Historic Market Size by Region
  3. 4.2.1 Global Multi-target MET TKIs Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Multi-target MET TKIs Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Multi-target MET TKIs Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Multi-target MET TKIs Forecasted Market Size by Region
  7. 4.3.1 Global Multi-target MET TKIs Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Multi-target MET TKIs Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Multi-target MET TKIs Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Multi-target MET TKIs by Application
  1. 5.1 Multi-target MET TKIs Market by Application
  2. 5.1.1 Medullary Thyroid Cancer
  3. 5.1.2 Non-small Cell Lung Cancer
  4. 5.1.3 Other
  5. 5.2 Global Multi-target MET TKIs Market Size by Application
  6. 5.2.1 Global Multi-target MET TKIs Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Multi-target MET TKIs Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Multi-target MET TKIs Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Multi-target MET TKIs Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Multi-target MET TKIs Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Multi-target MET TKIs Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Multi-target MET TKIs Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Multi-target MET TKIs Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 BDR Pharma
  2. 6.1.1 BDR Pharma Company Information
  3. 6.1.2 BDR Pharma Business Overview
  4. 6.1.3 BDR Pharma Multi-target MET TKIs Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 BDR Pharma Multi-target MET TKIs Product Portfolio
  6. 6.1.5 BDR Pharma Recent Developments
  7. 6.2 Beacon Pharmaceuticals
  8. 6.2.1 Beacon Pharmaceuticals Company Information
  9. 6.2.2 Beacon Pharmaceuticals Business Overview
  10. 6.2.3 Beacon Pharmaceuticals Multi-target MET TKIs Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Beacon Pharmaceuticals Multi-target MET TKIs Product Portfolio
  12. 6.2.5 Beacon Pharmaceuticals Recent Developments
  13. 6.3 Drug International
  14. 6.3.1 Drug International Company Information
  15. 6.3.2 Drug International Business Overview
  16. 6.3.3 Drug International Multi-target MET TKIs Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Drug International Multi-target MET TKIs Product Portfolio
  18. 6.3.5 Drug International Recent Developments
  19. 6.4 Elemento Pharma
  20. 6.4.1 Elemento Pharma Company Information
  21. 6.4.2 Elemento Pharma Business Overview
  22. 6.4.3 Elemento Pharma Multi-target MET TKIs Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Elemento Pharma Multi-target MET TKIs Product Portfolio
  24. 6.4.5 Elemento Pharma Recent Developments
  25. 6.5 Everest Pharmaceuticals
  26. 6.5.1 Everest Pharmaceuticals Company Information
  27. 6.5.2 Everest Pharmaceuticals Business Overview
  28. 6.5.3 Everest Pharmaceuticals Multi-target MET TKIs Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Everest Pharmaceuticals Multi-target MET TKIs Product Portfolio
  30. 6.5.5 Everest Pharmaceuticals Recent Developments
  31. 6.6 Exelixis
  32. 6.6.1 Exelixis Company Information
  33. 6.6.2 Exelixis Business Overview
  34. 6.6.3 Exelixis Multi-target MET TKIs Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Exelixis Multi-target MET TKIs Product Portfolio
  36. 6.6.5 Exelixis Recent Developments
  37. 6.7 Genvio Pharma
  38. 6.7.1 Genvio Pharma Company Information
  39. 6.7.2 Genvio Pharma Business Overview
  40. 6.7.3 Genvio Pharma Multi-target MET TKIs Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Genvio Pharma Multi-target MET TKIs Product Portfolio
  42. 6.7.5 Genvio Pharma Recent Developments
  43. 6.8 MSN Labs
  44. 6.8.1 MSN Labs Company Information
  45. 6.8.2 MSN Labs Business Overview
  46. 6.8.3 MSN Labs Multi-target MET TKIs Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 MSN Labs Multi-target MET TKIs Product Portfolio
  48. 6.8.5 MSN Labs Recent Developments
  49. 6.9 Zydus
  50. 6.9.1 Zydus Company Information
  51. 6.9.2 Zydus Business Overview
  52. 6.9.3 Zydus Multi-target MET TKIs Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Zydus Multi-target MET TKIs Product Portfolio
  54. 6.9.5 Zydus Recent Developments
  55. 6.10 Pfizer
  56. 6.10.1 Pfizer Company Information
  57. 6.10.2 Pfizer Business Overview
  58. 6.10.3 Pfizer Multi-target MET TKIs Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Pfizer Multi-target MET TKIs Product Portfolio
  60. 6.10.5 Pfizer Recent Developments
  61. 6.11 Stada Arzneimittel
  62. 6.11.1 Stada Arzneimittel Company Information
  63. 6.11.2 Stada Arzneimittel Business Overview
  64. 6.11.3 Stada Arzneimittel Multi-target MET TKIs Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Stada Arzneimittel Multi-target MET TKIs Product Portfolio
  66. 6.11.5 Stada Arzneimittel Recent Developments
  67. 6.12 Teva
  68. 6.12.1 Teva Company Information
  69. 6.12.2 Teva Business Overview
  70. 6.12.3 Teva Multi-target MET TKIs Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Teva Multi-target MET TKIs Product Portfolio
  72. 6.12.5 Teva Recent Developments
  73. 6.13 万邦医药
  74. 6.13.1 万邦医药 Company Information
  75. 6.13.2 万邦医药 Business Overview
  76. 6.13.3 万邦医药 Multi-target MET TKIs Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 万邦医药 Multi-target MET TKIs Product Portfolio
  78. 6.13.5 万邦医药 Recent Developments
  79. 6.14 Cipla
  80. 6.14.1 Cipla Company Information
  81. 6.14.2 Cipla Business Overview
  82. 6.14.3 Cipla Multi-target MET TKIs Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Cipla Multi-target MET TKIs Product Portfolio
  84. 6.14.5 Cipla Recent Developments
7 North America by Country
  1. 7.1 North America Multi-target MET TKIs Sales by Country
  2. 7.1.1 North America Multi-target MET TKIs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Multi-target MET TKIs Sales by Country (2021-2026)
  4. 7.1.3 North America Multi-target MET TKIs Sales Forecast by Country (2027-2032)
  5. 7.2 North America Multi-target MET TKIs Market Size by Country
  6. 7.2.1 North America Multi-target MET TKIs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Multi-target MET TKIs Market Size by Country (2021-2026)
  8. 7.2.3 North America Multi-target MET TKIs Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Multi-target MET TKIs Sales by Country
  2. 8.1.1 Europe Multi-target MET TKIs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Multi-target MET TKIs Sales by Country (2021-2026)
  4. 8.1.3 Europe Multi-target MET TKIs Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Multi-target MET TKIs Market Size by Country
  6. 8.2.1 Europe Multi-target MET TKIs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Multi-target MET TKIs Market Size by Country (2021-2026)
  8. 8.2.3 Europe Multi-target MET TKIs Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Multi-target MET TKIs Sales by Country
  2. 9.1.1 Asia-Pacific Multi-target MET TKIs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Multi-target MET TKIs Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Multi-target MET TKIs Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Multi-target MET TKIs Market Size by Country
  6. 9.2.1 Asia-Pacific Multi-target MET TKIs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Multi-target MET TKIs Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Multi-target MET TKIs Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Multi-target MET TKIs Sales by Country
  2. 10.1.1 South America Multi-target MET TKIs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Multi-target MET TKIs Sales by Country (2021-2026)
  4. 10.1.3 South America Multi-target MET TKIs Sales Forecast by Country (2027-2032)
  5. 10.2 South America Multi-target MET TKIs Market Size by Country
  6. 10.2.1 South America Multi-target MET TKIs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Multi-target MET TKIs Market Size by Country (2021-2026)
  8. 10.2.3 South America Multi-target MET TKIs Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Multi-target MET TKIs Sales by Country
  2. 11.1.1 Middle East and Africa Multi-target MET TKIs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Multi-target MET TKIs Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Multi-target MET TKIs Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Multi-target MET TKIs Market Size by Country
  6. 11.2.1 Middle East and Africa Multi-target MET TKIs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Multi-target MET TKIs Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Multi-target MET TKIs Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Multi-target MET TKIs Value Chain Analysis
  2. 12.1.1 Multi-target MET TKIs Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Multi-target MET TKIs Production Mode & Process
  7. 12.2 Multi-target MET TKIs Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Multi-target MET TKIs Distributors
  10. 12.2.3 Multi-target MET TKIs Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst